Portal de investigação
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1388-9842, 1879-0844
- Tipo:
- Letter
- Páginas:
- 2207-
- DOI:
- 10.1002/ejhf.2694
- Link para outro recurso:
- www.scopus.com
European Journal of Heart Failure Wiley-Blackwell
Documentos
- Não há documentos
Filiações
Keywords
- Heart; Heart Failure; Humans; dulaglutide; glucagon like peptide 1 receptor agonist; placebo; all cause mortality; cardiovascular mortality; disease classification; drug efficacy; drug safety; heart failure; hospitalization; human; Letter; medical history; non insulin dependent diabetes mellitus; publication; randomized controlled trial (topic); treatment outcome; complication; controlled study; heart; heart failure; randomized controlled trial
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Evaluation of thyroid function in patients hospitalized for acute heart failure
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Heart failure) . 2021
Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2021
Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Hydrodistension ) . 2022
Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Citar a publicação
Ferreira J,Neves J. Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial. Eur. J. Heart Fail. 2022. 24(11):p. 2207-2207. IF:18,200. (1).
